Enzymotec and Il Dong Sign Agreement in the Korean Market

Israeli biotech company Enzymotec and Korean pharmaceuticals manufacturer Il Dong have announced signing an agreement to launch a novel supplement for CVD prevention in the Korean market.

"Enzymotec has developed CardiaBeat(TM) which enhances the impact of phytosterols & omega-3 fatty acids, for reducing the risk for CVD. This product is based on our clinical trials and know-how "says Ms. Michal Haim-Bravman, Enzymotec’s marketing manager.

"South Korea is a strategic market for us. Its health supplements sector has more than doubled in the past years with sales estimated to be more than US$ 2 billion. Furthermore, the increase in the occurrence of obesity, heart disease, hypertension, and diabetes as well as consumers seeking for innovative self – medicate products, are all important indicators favoring launch of innovative products there" concludes, Ms. Haim-Bravman.

Enzymotec and Il Dong intend to develop additional biofunctional products for the Korean market, focusing on cognitive management and CVD solutions.

"We expect that the establishment of the strategic collaboration between Il Dong and Enzymotec will lead to acquire a leading position in the Korean nutraceutical market." says Dr. Ariel Katz, Enzymotec CEO

“We are very pleased to have an opportunity to provide unique and superior health benefits for our consumers with innovative biofunctional health food supplements in close collaboration with Enzymotec, one of the world top biotech companies specialized in various lipid-based applications through the development and manufacturing of structured phospholipids and sterols" says Mr. Kum-Ki Lee, CEO of Il Dong pharmaceutical and Il Dong Foodis Co.

Il Dong is one of the top leading research and marketing centered pharmaceutical companies in Korea, by manufacturing and supplying a wide range of therapeutic ethical and consumer drugs for more than 60 years.
Il Dong's affiliate company, Il Dong Food is is involved in various food and nutritional product business with nationwide sales networks covering all major supermarkets and consumer market places across the nation.

Enzymotec is an Israeli biotech company, who is developing and manufacturing bio-functional ingredients for the dietary supplements, functional foods and infant formula markets.

Ms. Michal Haim-Bravman
Marketing Manager
Enzymotec Ltd.
E-mail: [email protected]
Fax: +972-4-6443799

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.